Skip to content

Clinical trials

Observational beta-Thalassemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: beta-Thalassemia Phase: Observational Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20042
20051
20071
20091
20101
20111
20121
20134
20141
20161
20171
20183
20195
20207
20217
20225
20238
202410
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Unknown status19
Recruiting10
Not yet recruiting5
Active, not recruiting4
Enrolling by invitation3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University13
Nanfang Hospital, Southern Medical University3
Bioray Laboratories2
Bristol-Myers Squibb2
Celgene2
CorrectSequence Therapeutics Co., Ltd2
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia2
Hospital Universitari Vall d'Hebron Research Institute2
Medical University of Graz2
National Institute of Allergy and Infectious Diseases (NIAID)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
beta-Thalassemia69
Anemia, Sickle Cell16
Iron Overload7
Hemoglobinopathies5
Myelodysplastic Syndromes5
Thalassemia5
Anemia4
Cystic Fibrosis4
alpha-Thalassemia4
Crohn Disease3

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.